Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation

Area of Science:

• Cardiology
• Pharmacology
• Nutritional Science

Background:

• Atrial fibrillation (AF) is a common arrhythmia linked to significant health risks.
• Current antiarrhythmic drugs often fail due to targeting single mechanisms.
• Omega-3 polyunsaturated fatty acids (n-3 PUFAs) demonstrate potential for supraventricular arrhythmias.

Purpose of the Study:

• To review the antiarrhythmic effects of n-3 PUFAs.
• To examine epidemiological data on n-3 PUFA intake and AF incidence.
• To analyze clinical trial results on n-3 PUFA supplementation for AF prophylaxis and recurrence.

Main Methods:

• Literature review of current understanding of n-3 PUFA antiarrhythmic effects.
• Analysis of epidemiological studies linking n-3 PUFA consumption to AF incidence.
• Synthesis of findings from clinical trials on n-3 PUFA supplementation.

Main Results:

• n-3 PUFAs may exert antiarrhythmic effects via ionic channel modulation, improved membrane fluidity, and reduced inflammation/fibrosis.
• Epidemiological studies suggest a potential association between n-3 PUFA intake and lower AF incidence.
• Clinical trials are investigating the efficacy of n-3 PUFA supplementation in AF prevention and management.

Conclusions:

• n-3 PUFAs offer a multi-targeted approach to managing atrial fibrillation.
• Further research and clinical trials are warranted to confirm the role of n-3 PUFAs in AF treatment.
• Dietary intake and supplementation of n-3 PUFAs are areas of active investigation for cardiovascular health.